Abstract
Acute lymphoblastic leukemia is a malignant disorder of lymphoid progenitor cells. Advances in our understanding of lymphoblastic leukemia have mainly come from new molecular technologies and genomics. This article describes recent advances in our understanding of maturation arrest of leukemic cells, initial and subsequent gene defects and rearrangements, the role of chemokines, and lymphoid cell homing. These advances point to new ways of targeting leukemic cells.
MeSH terms
-
Adolescent
-
Cell Transformation, Neoplastic
-
Chemokines / physiology
-
Child
-
Chromosome Aberrations
-
Diseases in Twins
-
Female
-
Fetal Diseases / genetics
-
Fetal Diseases / pathology
-
Fetofetal Transfusion
-
Humans
-
Infant
-
Infant, Newborn
-
Lymphocyte Subsets / drug effects
-
Lymphocyte Subsets / pathology*
-
Male
-
Neoplastic Stem Cells / drug effects
-
Neoplastic Stem Cells / pathology*
-
Precursor Cell Lymphoblastic Leukemia-Lymphoma / embryology
-
Precursor Cell Lymphoblastic Leukemia-Lymphoma / epidemiology
-
Precursor Cell Lymphoblastic Leukemia-Lymphoma / genetics
-
Precursor Cell Lymphoblastic Leukemia-Lymphoma / pathology*
-
Pregnancy
-
Receptors, CCR7 / physiology
Substances
-
CCR7 protein, human
-
Chemokines
-
Receptors, CCR7